New Combination Treatment, Vyxeos, Approved for Acute Myeloid Leukemia

THURSDAY, Aug. 3, 2017 -- The combination chemotherapy drug Vyxeos (daunorubicin and cytarabine) has been approved by the U.S. Food and Drug Administration as the first treatment for certain high-risk types of acute myeloid leukemia (AML). AML is...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news